Data Insights

VSJ-110 by Vanda Pharmaceuticals for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval

VSJ-110 is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...

Likelihood of Approval and Phase Transition Success Rate Model - VSJ-110 in Keratoconjunctivitis Sicca (Dry Eye)

Data Insights

VTR-297 by Vanda Pharmaceuticals for Onychomycosis (Tinea Unguium): Likelihood of Approval

VTR-297 is under clinical development by Vanda Pharmaceuticals and currently in Phase I for Onychomycosis (Tinea Unguium). According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - VTR-297 in Onychomycosis (Tinea Unguium)

Data Insights

Tradipitant by Vanda Pharmaceuticals for Functional (Non Ulcer) Dyspepsia: Likelihood of Approval

Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Functional (Non Ulcer) Dyspepsia. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Tradipitant in Functional (Non Ulcer) Dyspepsia

Data Insights

VHX-896 by Vanda Pharmaceuticals for Bipolar I Disorder: Likelihood of Approval

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Bipolar I Disorder. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - VHX-896 in Bipolar I Disorder

Data Insights

VHX-896 by Vanda Pharmaceuticals for Schizophrenia: Likelihood of Approval

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III...

Likelihood of Approval and Phase Transition Success Rate Model - VHX-896 in Schizophrenia

Data Insights

Tradipitant by Vanda Pharmaceuticals for Motion Sickness: Likelihood of Approval

Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Motion Sickness. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Tradipitant in Motion Sickness

Data Insights

Iloperidone LAI by Vanda Pharmaceuticals for Schizophrenia: Likelihood of Approval

Iloperidone LAI is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Schizophrenia. According to GlobalData, Phase...

Data Insights

Ponesimod by Vanda Pharmaceuticals for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval

Ponesimod is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Plaque Psoriasis (Psoriasis Vulgaris). According to...